Eli Lilly’s Obesity Drug Zepbound Reduces Sleep Apnea in Late-Stage Studies
The injection lowered obstructive sleep apnea severity by up to nearly two-thirds in obese adults, with and without PAP therapy, in two phase 3 trials.
The injection lowered obstructive sleep apnea severity by up to nearly two-thirds in obese adults, with and without PAP therapy, in two phase 3 trials.
New research warns individuals scheduled for medical procedures to halt popular weight loss drugs like Ozempic and Wegovy prior to prevent aspiration pneumonia, a risk associated with these medications.
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines.
Funding awarded to scientists at Camino Pharma, Sanford Burnham Prebys, and UC San Diego will expand the nonclinical studies to support a phase 2 clinical evaluation of SBP-9330.
Read MoreThe new company, formed through a merger between Oxitope and Arxx, has a pipeline of selective antibodies that target inflammatory and fibrotic indications, including several first-in-class clinical candidates.
Read MoreThe inhaler contains a short-acting beta2-agonist to help relax the smooth muscles of the airways and an inhaled corticosteroid to help decrease inflammation in the lungs, treating both symptoms and inflammation.
Read MoreA stapled lipopeptide can successfully protect against infection by SARS-CoV-2, the virus that causes COVID-19.
Read MoreAAFA says the investigation opens an opportunity to address what patients report as the primary reason why people don’t adhere to their asthma treatment: the cost of prescribed asthma medication.
Read MoreResearchers say the study supports warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD.
Read MoreAn article published by the New York Times outlines how an FDA black box warning for the asthma drug Singulair (montelukast) did little to alert patients to its potential mental health side effects or to dissuade physicians from prescribing it.
Read MoreA Congressional committee led by Senator Bernie Sanders are demanding answers from pharmaceutical companies on the high costs of asthma inhalers, according to a report by The Hill.
Read MoreTheravance Biopharma’s COPD treatment Yupelri was not superior to Boehringer Ingelheim’s Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Read MoreCedars-Sinai investigators suggest it may be helpful to keep an eye on patients with underlying health issues after COVID-19 vaccination to monitor for post-vaccine POTS, a condition that causes an abnormal increase in heart rate after standing or sitting up.
Read MoreRespiratory syncytial virus vaccines recently approved for people 60 and older would dramatically reduce the disease’s burden of illness and death if they were widely adopted like annual influenza vaccines, a Yale University study finds.
Read MoreAstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.
Read More